Santen EMEA

Santen EMEA, established in 1890, is a prominent pharmaceutical company with a dedicated specialization in ophthalmology. Operating within the Healthcare and Pharmaceuticals sectors, the company focuses on delivering advanced ophthalmic products and comprehensive medical services. With a significant global presence indicated by its 10 locations and hashtags like #spain, #eu, and #europe, Santen EMEA has built a long-standing reputation for innovation and patient-centric care. Its core mission revolves around contributing to the well-being of patients by addressing various eye conditions through scientific expertise and cutting-edge treatments. The company's commitment extends to developing solutions for long-term vision health and disease management.

The organization employs between 500 - 1,000 professionals across its operations, reflecting a substantial workforce dedicated to its specialized field. Generating a revenue of $507.5M, Santen EMEA demonstrates robust financial performance and market penetration. The company's operational scope includes the development and distribution of prescription pharmaceuticals and medical devices aimed at improving eye care. For insights into the people driving these advancements, Meet Santen EMEA's team to learn more about their leadership and expertise.

Santen EMEA's product portfolio encompasses a range of ophthalmic solutions, including prescription pharmaceuticals, treatments for specific diseases, and innovative approaches like gene therapy. They also offer medical devices designed for eye care, emphasizing preservative-free formulations and advanced packaging like bio-plastic bottles. The company's track record in specialist ophthalmology underscores its role as a key player in advancing vision science and patient outcomes, ensuring long-term vision and overall well-being for individuals worldwide.